Research in Experimental Medicine

, Volume 187, Issue 5, pp 369–377 | Cite as

Semisoluble aminated glucan: Long-term efficacy against an intraperitonealE. coli challenge and its effect on formation of abdominal adhesions

  • S. M. Almdahl
  • R. Seljelid
Original Papers

Summary

The first part of this study in the rat was designed to assess the immediate and, in particular, the long-term effects of semisoluble aminated glucan (SAG) with regard to an intraperitoneal (i.p.)E. coli challenge and side-effects. The severity of theE. coli peritonitis was evaluated by quantification of the concomitant bacteremia. The animals randomly received either 10 ml normal saline i.p. (controls) or 10 ml (50 mg) SAG i.p. (experimental groups). It was found that SAG had no immediate protective effect against the infectious challenge as no difference was detected in the bacterial clearance between saline- and SAG-treated rats at day 0. However, 2 days after injection of saline/SAG a substantial protection of SAG was noted as no blood-borne bacteria could be detected at 1, 2, 3, 4 and 5 h after theE. coli challenge in SAG-treated animals, whereas by contrast matching blood cultures were positive in all controls. A likewise protective effect againstE. coli bacteremia of a single i.p. injection of SAG was demonstrated at 7, 21, and 49 days after the administration of the compound. During the 7-week experimental period no clinical side-effects of SAG were observed. At autopsy (days 0, 2, 7, 21, and 49, respectively) no gross pathologic conditions were found. Lung, spleen, and kidney sections from SAG-treated rats were normal, whereas tiny granulomas were exhibited in liver sections, possibly related to the hyperfunctional macrophage state which SAG induced. The second main object of the study was to evaluate SAG's effect on adhesion formation. Intraperitoneal adhesions were induced by excision 1 × 3 cm of the peritoneum and underlying muscle, subsequently closing the defect with interrupted sutures. After closure of the abdominal wall the rats received at random either 10 ml saline or 10 ml SAG i.p. Quantitative assessment of adhesions 1 week later demonstrated a significant (P = 0.05) reduction in SAG-treated rats as compared to controls. Both SAG and dextran 70 are high-molecular weight carbohydrates and the latter is in wide clinical use. The third aim of the study therefore was to elucidate whether dextran 70 also might confer protection against an i.p.E. coli challenge. The data did not support this idea. There was no difference in the number of blood-borne bacteria between dextran- and saline-treated animals.

Key words

Abdominal adhesions Aminated glucan, semisoluble Dextran 70 E. coli Peritonitis Rats 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Almdahl SM, Bögwald J, Hoffman J, Giercksky K-E, Seljelid R (1987) Protection by aminated glucan in experimental endogenous peritonitis. Eur Surg Res 19:78–85PubMedGoogle Scholar
  2. 2.
    Almdahl SM, Bögwald J, Hoffman J, Seljelid R (1987) Treatment of experimental peritonitis in rats by transfer of peritoneal mononuclear cells from animals treated with semisoluble aminated glucan. Acta Chir Scand 153:535–539PubMedGoogle Scholar
  3. 3.
    Almdahl SM, Bögwald J, Hoffman J, Sjunneskog C, Seljelid R (1987) The effect of splenectomy onE. coli and its treatment by semisoluble aminated glucan. Scand J Gastroenterol 22:261–267PubMedGoogle Scholar
  4. 4.
    Aszodi A, Chaimoff C, Dintsman M (1972) Rheomacrodex in the prevention of intraperitoneal adhesions. Int Surg 57:559–561PubMedGoogle Scholar
  5. 5.
    Bunt TJ (1985) Urgent relaparotomy: the high-risk, no-choice operation. Surgery 98:555–560PubMedGoogle Scholar
  6. 6.
    Bögwald J, Seljelid R, Hoffman J (1986) Coupling of polysaccharides activated by means of chloroacetaldehyde dimethylacetal to amines or proteins by reductive amination. Carbohydrate Res 148:101–107Google Scholar
  7. 7.
    Choate W, Just-Viera J, Yeager G (1964) Prevention of experimental peritoneal adhesions by dextran. Arch Surg 88:249–254PubMedGoogle Scholar
  8. 8.
    DiLuzio NR, Williams DL (1978) Protective effect of glucan against systemicS. aureus septicemia in normal and leukemic mice. Infect Immun 20:804–810PubMedGoogle Scholar
  9. 9.
    Ellis H (1980) Internal overhealing: the problem of intraperitoneal adhesions. World J Surg 4:303–306PubMedGoogle Scholar
  10. 10.
    Fabri PJ, Ellison EC, Anderson ED, Kudsk KA (1983) High-molecular weight dextran. Effect on adhesion formation and peritonitis in rats. Surgery 94:336–340PubMedGoogle Scholar
  11. 11.
    Gilmore OJA, Reid C (1976) Noxytiolin and peritoneal adhesion formation. Br J Surg 63:978–980PubMedGoogle Scholar
  12. 12.
    Hau T, Payne WD, Simmons RL (1979) Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 148:415–418PubMedGoogle Scholar
  13. 13.
    Hoffman EO, DiLuzio NR, Cook JA, McNamee R, Armstrong K (1977) The morphologic effects of glucan in the liver, lung, and spleen of the rat: Light- and electron-microscopic studies. Lab Invest 36:340Google Scholar
  14. 14.
    Holtz G, Baker E (1980) Inhibition of peritoneal adhesion formation after lysis with thirty-two percent dextran 70. Fertil Steril 34:394–395PubMedGoogle Scholar
  15. 15.
    Lindenberg S, Moesgaard F, Vangsted P, Lykkegaard Nilsen M (1982) Peritoneal dialyses reduces intraperitoneal adhesion formation. Eur Surg Res 14:274–278PubMedGoogle Scholar
  16. 16.
    Moustoukas N, Browder W, Gleason C, DiLuzio NR, Nichols RL (1985) Adverse effect of splenectomy in experimental peritonitis. J Surg Res 38:574–581PubMedGoogle Scholar
  17. 17.
    Muzaffar TZ, Stalker AL, Bryce WAJ, Dhall DP (1972) Structural alterations of fibrin clots with dextran. Thromb diath Haemorrh 28:257–267PubMedGoogle Scholar
  18. 18.
    Neuwirth RS, Khalaf SM (1975) Effects of thirty-two percent dextran 70 on peritoneal adhesion formation. Am J Obstet Gynecol 121:420–422PubMedGoogle Scholar
  19. 19.
    Reikerås O, Nordstrand K (1985) Use of dextran to prevent intraperitoneal adhesions caused by maize starch powder. Eur Surg Res 17:251–253PubMedGoogle Scholar
  20. 20.
    Seljelid R (1987) Effector functions of macrophages. Acta Med Scand (in press)Google Scholar
  21. 21.
    Seljelid R, Bögwald J, Hoffman J, Larm O (1984) A soluble β 1–3d-glucan derivative potentiates the cytostatic and cytolytic capacity of mouse peritoneal macrophages in vitro. Immunopharmacology 7:69–73PubMedGoogle Scholar
  22. 22.
    Seljelid R, Bögwald J, Lundwall Å (1981) Glycan stimulation of macrophages in vitro. Exp Cell Res 131:121–129PubMedGoogle Scholar
  23. 23.
    Seljelid R, Bögwald J, Rasmussen LT, Larm O, Hoffman J, Berge A, Ugelstad J (1985) In vivo activation of mouse macrophages with β 1–3d-glucan-derivatized plastic beads. Scand J Immunol 21:601–605PubMedGoogle Scholar
  24. 24.
    Soules MR, Dennis L, Bosarge A, Moore DE (1982) The prevention of postoperative pelvic adhesions: an animal study comparing barrier methods with dextran 70. Am J Obstet Gynecol 143:829–834PubMedGoogle Scholar
  25. 25.
    Tangen O, Wik KO, Almquist IAM, Arfors KE (1972) Effects of dextran on the structure and plasmin-induced lysis of human fibrin. Thromb Res 1:487–492Google Scholar
  26. 26.
    Williams DL, Browder W, DiLuzio NR (1983) Immunotherapeutic modification ofEscherichia coli-induced experimental peritonitis and bacteremia by glucan. Surgery 93:448–454PubMedGoogle Scholar
  27. 27.
    Williams DL, Cook JA, Hoffman EO, DiLuzio NR (1978) Protective effect of glucan in experimentally induced candidiasis. J Reticuloendothel Soc 23:479–490PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • S. M. Almdahl
    • 1
  • R. Seljelid
    • 1
  1. 1.Dept. of SurgeryUniversity Hospital and Institute of Medical Biology, University of TromsøTromsøNorway

Personalised recommendations